Results

Total Results: 1,795 records

Showing results for "cost".

121. #05 DEPRESSION (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1506.pdf
     June 01, 2015 - pursuing labeling for treating BPD or MDD, and third-party payers generally do not reimburse its cost … informal clinical practice listings and patient self-reports, IV ketamine treatments for BPD and MDD cost … Multiple experts also opined that direct cost to patients, unresolved dosing protocols, and safety … Transderm Scop pricing. [internet]. Santa Monica (CA): GoodRx, Inc. … Methscopolamine (Pamine Forte, Pamine) pricing. [internet]. Santa Monica (CA): Good Rx, Inc.

122. PREGNANCY, INCLUDING PRETERM BIRTH #12 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/12_pregnancy_potential_high_impact_2012-12-11.pdf
     January 01, 2012 - the highest potential for impact on clinical care, the health care system, patient outcomes, and costs … Costs for donated breast milk are reported to be between $3 and $5 per ounce with additional costs … . 10 In contrast, infant formula costs between 71 and 83 cents per ounce and may be provided free … health conditions including septicemia and lifelong developmental disorders. 11 Despite potential cost … Many experts believe there may be an initial increase in costs, but the reduction in costs stemming

123. Comparative Effectiveness Review Disposition of Comments Report (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-chronic-conditions-interventions_disposition-comments.pdf
     August 13, 2012 - Inherent in any new model of payment will be the discussion of both absolute costs and the cost-effectiveness … While cost-effectiveness is outside the scope of this review, we have added data about costs from the … The lack of cost comparisons should be stated as an important research gap (page 50-51). … I was looking for a summary of cost comparisons earlier on in report. … Although cost-effectiveness is beyond the scope of this review, we have added data on costs to the report

124. Icd-Categories-Prevalence-Reimbursement Research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/icd-categories-prevalence-reimbursement_research.pdf
     January 01, 2011 - reimbursement by recurrent International Classification of Diseases categories, 2006-2009 Utilization and Costs … High costs are associated with many chronic diseases that are increasing in prevalence, including mental … STUDY PERIOD The study period over which disease burden and costs were examined was 2006-2009. … The relationships among age, chronic conditions, and health care costs. … Utilization and Costs.

125. Comparative Effectiveness Review Disposition of Comments Report (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/bundled-payments-quality-effects_disposition-comments.pdf
     August 24, 2012 - Has it impacted cost? What can we learn about a proven paradigm? … Also, cost-sharing and limits on coverage are discussed for some settings, but not others. … Both these factors further erode potential cost savings from bundled payments. … We also note the distinction between aggregate spending and costs and per-episode spending and costs … We note the distinction between aggregate spending/costs and per-episode spending/costs in the same

126. Which interventions are effective in decreasing heart failure readmissions? | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/which-interventions-are-effective-in-decreasing-heart-failure-readmissions
     February 27, 2012 - Heart failure is the leading cause of rehospitalizations among elderly Americans, and inpatient care costs … for acute decompensated heart failure cost over $20 billion in 2009. … guideline development, and ultimately improve the quality of care by reducing morbidity, mortality, and costs … guideline development, and ultimately improve the quality of care by reducing morbidity, mortality, and costs

127. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1412.pdf
     December 01, 2014 - Historically, pricing, reimbursement, and prescribing barriers have been the priority for the manufacturers … The yearly cost per patient would be about $13,000 at current pricing. … : EnteroMedics has not announced device costs or estimated procedure costs. … of the device and surgical installation, the costs of which are considerable. … If pricing is similar for the obesity indication, such a carton would provide 18 doses at the 3 mg

128. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1512.pdf
     December 29, 2015 - High cost could limit patient access to the drug. … of treatment costs. … the majority of treatment costs. … Cosentyx pricing info. [internet]. Santa Monica (CA): GoodRx, Inc. … Tofacitinib pricing info. [internet]. Santa Monica (CA): GoodRx, Inc.

129. Topic Brief: Regenerative Medicine for Musculoskeletal (pdf file)
     effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-regenerative-medicine-musculoskeletal.pdf
     January 01, 2021 - In 2016, such disorders impacted approximately one in two (or 126.6 million) Americans and cost society … which the cartilage protecting the joint wears down, affects over 32.5 million American adults2 and cost … which the cartilage protecting the joint wears down, affects over 32.5 million American adults 2 and cost … Represents high costs due to common use, high unit costs, or high associated costs to consumers, to … which the cartilage protecting the joint wears down, affects over 32.5 million American adults 2 and cost

130. Topic Brief: Regenerative Medicine for Musculoskeletal (pdf file)
     effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-regenerative-medicine-musculoskeletal_0.pdf
     January 01, 2021 - In 2016, such disorders impacted approximately one in two (or 126.6 million) Americans and cost society … which the cartilage protecting the joint wears down, affects over 32.5 million American adults2 and cost … which the cartilage protecting the joint wears down, affects over 32.5 million American adults 2 and cost … Represents high costs due to common use, high unit costs, or high associated costs to consumers, to … which the cartilage protecting the joint wears down, affects over 32.5 million American adults 2 and cost

131. Reducing Hospital Length of Stay Supplemental Info (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/topic-nom-length-stay-supplement.pdf
     June 27, 2019 - Most academic centers are overutilized because of complexity of care / cost shifting from smaller hospitals … In addition: • Reducing LOS reduces the risk of patient harms in the hospital and the cost of care … for health systems, thereby improving health systems’ bottom line; it may also reduce costs for payers

132. EPC-Pilot-Project-A-Dual-Approach-To-Facilitate-Health-Systems-Uptake-Of-Evidence-Synthesis-Reports-Anxiety-In-Children (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-anxiety-children_0.pdf
     October 01, 2018 - This includes information on costs, resources, patients’ values, acceptability and feasibility of interventions … It contained 6 headings (Which Patients Have Been Studied, Values & Preferences, Costs & Resources, … Sources for costs and treatment length were gathered from Mayo Clinic resources. … The cost card seemed to be the least used, insurance differences, varying regional costs of treatment … Examples would be cost-effectiveness analyses and modelling studies to inform cost questions, implementation

133. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1506.pdf
     June 01, 2015 - the majority of treatment costs. … However, these costs may be offset by decreased use of other health care resources. … treatment costs. … However, these costs may be offset by decreased use of other health care resources. … Secukinumab pricing info. [internet]. Santa Monica (CA): GoodRx, Inc.

134. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1312.pdf
     January 01, 2016 - Experts thought that the intervention would reduce per-patient treatment costs, compared with costs … The surgery could increase short-term costs of T2DM care but might offset costs over time if long-term … $18,250, which might provide a pricing benchmark for the fluocinolone acetonide implant. … -based, online aggregator of pharmacy pricing listed ranibizumab cost at about $2,000 per vial with … But one clinical expert stated that although costs are currently high, per-patient costs and costs

135. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1512.pdf
     December 01, 2015 - the highest potential for impact on clinical care, the health care system, patient outcomes, and costs … Costs for the Cytosponge device have not been widely reported yet. … As of November 2015, rifaximin costs shown on GoodRx, an aggregator of pharmacies’ drug prices, are … The patient gets the test done in a familiar location at low cost. … Xifaxan pricing info. [internet]. Santa Monica (CA): GoodRx, Inc.

136. Infectious Disease Including HIV/AIDS #09 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/09_infectiousdisease_potential_high_impact_june_2012.pdf
     January 01, 2012 - Experts speculated that this, combined with high treatment costs and likely high out-of-pocket costs … an estimated $1,100 per week (wholesale acquisition cost). 11 The therapy’s total cost depends on … This, combined with high treatment costs and likely high out-of-pocket costs to patients for something … Experts generally viewed the procedure as cost-neutral or cost-saving compared to multiple failed courses … expects to file for U.S. regulatory approval in 2012, with an expected launch date of 2013–2014. 170 Pricing

137. Developing Evidence-Based Research Priorities for Off-Label Drug Use | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/off-label-use-research-priorities/research
     June 29, 2009 - The second was high drug cost. … evidence occurring for the correlated features of recent drug approval, aggressive marketing and higher costs … greatest cost formed the cost index. … cost for any drug on the list. … The Combined Cost and Marketing index value is the equal weighted average of the Drug Cost, Corporate

138. Future Research Needs for Diagnosis of Obstructive Sleep Apnea (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/sleep-apnea-diagnosis-future_research.pdf
     February 01, 2012 - low-cost portable devices 4. … Out-of-pocket patient costs should also be included in cost estimates. … An example of such a cost, which would not be included in most analyses, was the costs to a long-haul … Out-of-pocket patient costs should also be included. … Represents high costs due to common use, to high unit costs, or to high associated costs to consumers

139. Early Imaging for Back Pain and Clinical Outcomes in Older Adults: A Brief Summary of Findings and Key Points for Clinician-Patient Discussions | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/back-pain-imaging/clinician
     May 13, 2016 - may lead to followup interventions that are not beneficial and may be associated with harms and high costs … Other Findings of the Study One-year use and costs of health care resources were significantly higher … Overall costs (including costs for use of health care resources, imaging procedures, and medications) … This increase in cost was in the absence of a clinical benefit. … be of benefit in caring for patients with back pain but is associated with more testing and higher costs

140. Back-Pain-Imaging Clinician (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/back-pain-imaging_clinician.pdf
     April 01, 2016 - may lead to followup interventions that are not beneficial and may be associated with harms and high costs … OTHER FINDINGS OF THE STUDY One-year use and costs of health care resources were significantly higher … the early radiograph and early MRI/CT groups than in the no early imaging control group. »» Overall costs … (including costs for use of health care resources, imaging procedures, and medications) were 27-percent … This increase in cost was in the absence of a clinical benefit.